{"transactions":[{"id":1967251,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115883,"kind":"person","name":"Shani Eli","position":1,"cik":"0001876642","reported_name":"Shani Eli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Global Marketing&Portfolio"}}],"security":"Restricted Share Units","published_at":"2023-03-07T21:13:03.000Z","date":"2023-03-05","kind":"exercise","acquired":false,"shares":5896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 5, 2021, with 5,896 vested on each of March 5, 2022 and March 5, 2023, 5,896 vesting on March 5, 2024, and 5,898 vesting on March 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 5, 2021, with 5,896 vested on each of March 5, 2022 and March 5, 2023, 5,896 vesting on March 5, 2024, and 5,898 vesting on March 5, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":11794,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5896},"source":{"system":"sec-edgar","filing":"0001209191-23-016719","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016719/doc4.xml","form_type":"4"}},{"id":1967250,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115883,"kind":"person","name":"Shani Eli","position":1,"cik":"0001876642","reported_name":"Shani Eli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Global Marketing&Portfolio"}}],"security":"Restricted Share Units","published_at":"2023-03-07T21:13:03.000Z","date":"2023-03-04","kind":"exercise","acquired":false,"shares":20107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on March 4, 2022, with 20,107 vested on March 4, 2023, and 20,107 vesting on each of March 4, 2024, March 4, 2025 and March 4, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on March 4, 2022, with 20,107 vested on March 4, 2023, and 20,107 vesting on each of March 4, 2024, March 4, 2025 and March 4, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":60321,"derivative":{"underlying":"Ordinary Shares","underlying_shares":20107},"source":{"system":"sec-edgar","filing":"0001209191-23-016719","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016719/doc4.xml","form_type":"4"}},{"id":1967249,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115883,"kind":"person","name":"Shani Eli","position":1,"cik":"0001876642","reported_name":"Shani Eli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Global Marketing&Portfolio"}}],"security":"Restricted Share Units","published_at":"2023-03-07T21:13:03.000Z","date":"2023-03-04","kind":"exercise","acquired":false,"shares":3173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 4, 2019, with 3,173 vested on each of March 4, 2021, March 4, 2022, and March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 4, 2019, with 3,173 vested on each of March 4, 2021, March 4, 2022, and March 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3173},"source":{"system":"sec-edgar","filing":"0001209191-23-016719","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016719/doc4.xml","form_type":"4"}},{"id":1967248,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115883,"kind":"person","name":"Shani Eli","position":1,"cik":"0001876642","reported_name":"Shani Eli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Global Marketing&Portfolio"}}],"security":"Restricted Share Units","published_at":"2023-03-07T21:13:03.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":59760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on March 3, 2023, with 14,940 vesting on each of March 3, 2024, March 3, 2025, March 3, 2026, and March 3, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on March 3, 2023, with 14,940 vesting on each of March 3, 2024, March 3, 2025, March 3, 2026, and March 3, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":59760,"derivative":{"underlying":"Ordinary Shares","underlying_shares":59760},"source":{"system":"sec-edgar","filing":"0001209191-23-016719","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016719/doc4.xml","form_type":"4"}},{"id":1967247,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115883,"kind":"person","name":"Shani Eli","position":1,"cik":"0001876642","reported_name":"Shani Eli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Global Marketing&Portfolio"}}],"security":"Ordinary Shares","published_at":"2023-03-07T21:13:03.000Z","date":"2023-03-05","kind":"exercise","acquired":true,"shares":5896,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":54228,"source":{"system":"sec-edgar","filing":"0001209191-23-016719","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016719/doc4.xml","form_type":"4"}},{"id":1967246,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115883,"kind":"person","name":"Shani Eli","position":1,"cik":"0001876642","reported_name":"Shani Eli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Global Marketing&Portfolio"}}],"security":"Ordinary Shares","published_at":"2023-03-07T21:13:03.000Z","date":"2023-03-04","kind":"exercise","acquired":true,"shares":20107,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":48332,"source":{"system":"sec-edgar","filing":"0001209191-23-016719","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016719/doc4.xml","form_type":"4"}},{"id":1967245,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115883,"kind":"person","name":"Shani Eli","position":1,"cik":"0001876642","reported_name":"Shani Eli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Global Marketing&Portfolio"}}],"security":"Ordinary Shares","published_at":"2023-03-07T21:13:03.000Z","date":"2023-03-04","kind":"exercise","acquired":true,"shares":3173,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":28225,"source":{"system":"sec-edgar","filing":"0001209191-23-016719","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016719/doc4.xml","form_type":"4"}},{"id":1981789,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115883,"kind":"person","name":"Shani Eli","position":1,"cik":"0001876642","reported_name":"Shani Eli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Global Marketing&Portfolio"}}],"security":"Restricted Share Units","published_at":"2023-03-02T12:37:44.000Z","date":"2023-02-28","kind":"exercise","acquired":false,"shares":5311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on February 28, 2020 with 5,311 vested on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 5,312 vesting on February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on February 28, 2020 with 5,311 vested on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 5,312 vesting on February 28, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":5312,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5311},"source":{"system":"sec-edgar","filing":"0001209191-23-014441","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123014441/doc4.xml","form_type":"4"}},{"id":1981788,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115883,"kind":"person","name":"Shani Eli","position":1,"cik":"0001876642","reported_name":"Shani Eli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Global Marketing&Portfolio"}}],"security":"Ordinary Shares","published_at":"2023-03-02T12:37:44.000Z","date":"2023-02-28","kind":"exercise","acquired":true,"shares":5311,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":25052,"source":{"system":"sec-edgar","filing":"0001209191-23-014441","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123014441/doc4.xml","form_type":"4"}},{"id":2188620,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115883,"kind":"person","name":"Shani Eli","position":1,"cik":"0001876642","reported_name":"Shani Eli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Global Marketing&Portfolio"}}],"security":"Restricted Share Units","published_at":"2022-08-11T11:05:25.000Z","date":"2022-08-10","kind":"exercise","acquired":false,"shares":1581,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on August 10, 2018, with 1,581 vesting on August 10, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on August 10, 2018, with 1,581 vesting on August 10, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1581},"source":{"system":"sec-edgar","filing":"0001209191-22-045351","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122045351/doc4.xml","form_type":"4"}},{"id":2188619,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115883,"kind":"person","name":"Shani Eli","position":1,"cik":"0001876642","reported_name":"Shani Eli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Global Marketing&Portfolio"}}],"security":"Ordinary Shares","published_at":"2022-08-11T11:05:25.000Z","date":"2022-08-10","kind":"exercise","acquired":true,"shares":1581,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":19741,"source":{"system":"sec-edgar","filing":"0001209191-22-045351","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122045351/doc4.xml","form_type":"4"}},{"id":2345943,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115883,"kind":"person","name":"Shani Eli","position":1,"cik":"0001876642","reported_name":"Shani Eli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Global Marketing&Portfolio"}}],"security":"Restricted Share Units","published_at":"2022-03-08T21:13:07.000Z","date":"2022-03-05","kind":"exercise","acquired":false,"shares":5896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on March 5, 2021, with 5,896 having vested on March 5, 2022, 5,896 vesting on each of March 5, 2023 and March 5, 2024, and 5,898 vesting on March 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on March 5, 2021, with 5,896 having vested on March 5, 2022, 5,896 vesting on each of March 5, 2023 and March 5, 2024, and 5,898 vesting on March 5, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":17690,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5896},"source":{"system":"sec-edgar","filing":"0001209191-22-017061","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017061/doc4.xml","form_type":"4"}},{"id":2345942,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115883,"kind":"person","name":"Shani Eli","position":1,"cik":"0001876642","reported_name":"Shani Eli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Global Marketing&Portfolio"}}],"security":"Restricted Share Units","published_at":"2022-03-08T21:13:07.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":80428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 4, 2022, with 20,107 vesting on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 4, 2022, with 20,107 vesting on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":80428,"derivative":{"underlying":"Ordinary Shares","underlying_shares":80428},"source":{"system":"sec-edgar","filing":"0001209191-22-017061","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017061/doc4.xml","form_type":"4"}},{"id":2345941,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115883,"kind":"person","name":"Shani Eli","position":1,"cik":"0001876642","reported_name":"Shani Eli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Global Marketing&Portfolio"}}],"security":"Restricted Share Units","published_at":"2022-03-08T21:13:07.000Z","date":"2022-03-04","kind":"exercise","acquired":false,"shares":3173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on March 4, 2019, with 3,173 vesting on each of March 4 2022 and March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on March 4, 2019, with 3,173 vesting on each of March 4 2022 and March 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":3173,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3173},"source":{"system":"sec-edgar","filing":"0001209191-22-017061","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017061/doc4.xml","form_type":"4"}},{"id":2345940,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115883,"kind":"person","name":"Shani Eli","position":1,"cik":"0001876642","reported_name":"Shani Eli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Global Marketing&Portfolio"}}],"security":"Ordinary Shares","published_at":"2022-03-08T21:13:07.000Z","date":"2022-03-05","kind":"exercise","acquired":true,"shares":5896,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":18160,"source":{"system":"sec-edgar","filing":"0001209191-22-017061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017061/doc4.xml","form_type":"4"}},{"id":2345939,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115883,"kind":"person","name":"Shani Eli","position":1,"cik":"0001876642","reported_name":"Shani Eli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Global Marketing&Portfolio"}}],"security":"Ordinary Shares","published_at":"2022-03-08T21:13:07.000Z","date":"2022-03-04","kind":"exercise","acquired":true,"shares":3173,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":12264,"source":{"system":"sec-edgar","filing":"0001209191-22-017061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017061/doc4.xml","form_type":"4"}},{"id":2363045,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115883,"kind":"person","name":"Shani Eli","position":1,"cik":"0001876642","reported_name":"Shani Eli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Global Marketing&Portfolio"}}],"security":"Restricted Share Units","published_at":"2022-03-02T12:53:08.000Z","date":"2022-02-28","kind":"exercise","acquired":false,"shares":5311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on February 28, 2020, with 5,311 having vested on each of February 28, 2021 and February 28, 2022,\n5,311 vesting on February 28, 2023 and 5,312 vesting on February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on February 28, 2020, with 5,311 having vested on each of February 28, 2021 and February 28, 2022,\n5,311 vesting on February 28, 2023 and 5,312 vesting on February 28, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":10623,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5311},"source":{"system":"sec-edgar","filing":"0001209191-22-014474","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122014474/doc4.xml","form_type":"4"}},{"id":2363044,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115883,"kind":"person","name":"Shani Eli","position":1,"cik":"0001876642","reported_name":"Shani Eli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Global Marketing&Portfolio"}}],"security":"Ordinary Shares","published_at":"2022-03-02T12:53:08.000Z","date":"2022-02-28","kind":"sale","acquired":false,"shares":5311,"price":8.1422,"value":43243.2242,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.035 to $8.255,\ninclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full\ninformation regarding the number of shares sold at each separate price."}],"balance_after":9091,"source":{"system":"sec-edgar","filing":"0001209191-22-014474","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122014474/doc4.xml","form_type":"4"}},{"id":2363043,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115883,"kind":"person","name":"Shani Eli","position":1,"cik":"0001876642","reported_name":"Shani Eli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,Global Marketing&Portfolio"}}],"security":"Ordinary Shares","published_at":"2022-03-02T12:53:08.000Z","date":"2022-02-28","kind":"exercise","acquired":true,"shares":5311,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":14402,"source":{"system":"sec-edgar","filing":"0001209191-22-014474","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122014474/doc4.xml","form_type":"4"}}]}